Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by Busyzzindahouseon Jul 10, 2018 10:53am

82 Views

Post# 28292853

RE:Facts for the idiots who are bashing

Yup, no brainer to accumulate here.

Litemupp wrote: 1. Kaly has money now.... so watch out
2. Days like today are perfect for shorts covering and accumulation for traders, it ususally take months to accumulate those many shares and prices usually remain depressed for that period..It is very good IMO..now we might see some action soon.
3. FDA meeting is a catalyst to move prices up, so kudos to team Kaly as they choose perfect time for bringing money in.. They know that they can get maximum amount at this moment, unfortunatly price is down, so they had no other option.

Just wait and watch folks.